Inresa

What Inresa does

INRESA (legal entity Inresa SAS) is a French pharmaceutical laboratory headquartered in Bartenheim, France, founded in 2000. The company operates a specialized pharmaceutical product portfolio organized into four core lines: Médicaments (pharmaceutical medications), Matières premières à usage pharmaceutique (raw materials for pharmaceutical use), Véhicules pour préparations buvables (vehicles for drinkable preparations), and Plaies et cicatrisation (wound care and healing products). INRESA positions itself as an end-to-end partner for healthcare professionals, offering services spanning pharmaceutical registration, pharmaceutical activities, logistics, and commercialization.

The company serves a healthcare professional customer base that includes pharmacists, hospitals, and medical practitioners, distributing products through a direct sales motion in the domestic French market only. Distribution is supported by a professional team that provides product information and usage services, with a dedicated pharmacovigilance function ([email protected]) and an on-call contact line. Marketing is conducted through the corporate website, a LinkedIn presence, and active participation in industry conferences including the Journées Cicatrisations 2026 and JAPC 2025 wound care events.

INRESA is a privately held company with 11-50 employees, no disclosed funding, no public revenue figures, and no parent company. It generates revenue through one-time sales of its pharmaceutical products, with pricing not publicly disclosed. The company's competitive positioning is based on its regulatory expertise as a licensed French pharmaceutical laboratory, its diversified four-line product portfolio, and its direct relationships with healthcare professionals across France.

Name

Inresa

Legal name

Inresa SAS

Website

https://inresa-pharma.fr

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

INRESA is a French pharmaceutical laboratory (Inresa SAS, founded 2000, Bartenheim) that develops, registers, and distributes medications, pharmaceutical raw materials, vehicles for drinkable preparations, and wound care products to healthcare professionals across France.

Ownership category

akta.pro rank

Headquarters

HQ city

Bartenheim

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical product sales: INRESA generates revenue through the development, registration, manufacturing, logistics, and commercialization of pharmaceutical products including medications, pharmaceutical raw materials, vehicles for drinkable preparations, and wound healing products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Inresa SAS is a French pharmaceutical laboratory that develops, registers, manufactures, and commercializes pharmaceutical products for healthcare professionals. Its portfolio includes pharmaceutical medications, pharmaceutical-grade raw materials, vehicles for drinkable preparations, and wound care and healing products, complemented by end-to-end services spanning pharmaceutical registration, logistics, and commercialization.

Product overview

Inresa is a French pharmaceutical laboratory (Inresa SAS) offering a diversified portfolio of four core product lines: Médicaments (pharmaceutical medications), Matières premières à usage pharmaceutique (raw materials for pharmaceutical use), Véhicules pour préparations buvables (vehicles for drinkable preparations), and Plaies et cicatrisation (wound care and healing products). The company provides end-to-end services including pharmaceutical activities, registration/enregistrement, logistics, and commercialization, positioning itself as a comprehensive partner for healthcare professionals.

Differentiator

Problem solved

Functional benefit

Products and services

• Médicaments (Pharmaceutical Medications)

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• Mölnlycke Health Care: Swedish wound care and surgical solutions major; comparable product overlap with Inresa's wound-healing range but a global, multi-category incumbent.
• Smith & Nephew: Global medical devices company with a significant advanced wound management franchise, comparable category overlap with Inresa's wound-healing business.
• Paul Hartmann AG: European medical and wound care products manufacturer with overlapping wound-care and dressing offerings relevant to Inresa's portfolio.
• ConvaTec: Global medical products company with a wound care and skin care portfolio, broadly comparable to Inresa's Plaies et cicatrisation product line.
• Coloplast: Global leader in wound care and ostomy, overlapping with Inresa's Plaies et cicatrisation line but operating at vastly larger scale and broader geographic footprint.
• B. Braun Melsungen: Diversified European medical and pharmaceutical company with hospital-facing distribution and wound/infusion therapies that overlap with Inresa's healthcare professional value proposition.

Direct peers

• Laboratoire Cooper: French pharmaceutical laboratory distributing medications and healthcare products through a similar healthcare-professional channel, comparable in scope and mid-sized independent pharma lab profile.
• Mayoly Spindler: Mid-sized French pharmaceutical laboratory with a diversified specialty pharma and consumer health portfolio, comparable to Inresa in size, GTM motion, and French-market focus.
• Brothier (Laboratoire Brothier): French specialty pharmaceutical laboratory with a strong wound-care franchise (e.g., Algostéril), directly comparable to Inresa's wound-healing line and overall laboratory positioning.
• Laboratoires Urgo (Urgo Medical): French specialty pharmaceutical laboratory focused on wound care and healing, with overlapping Plaies et cicatrisation positioning and a comparable France-centric distribution model to Inresa.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/inresa-pharma
• Facebookfacebook.com/inresabartenheim

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Inresa